These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9422732)

  • 21. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
    Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Separation and purification of an endogenous inhibitor of sodium pump from chansu by thin-layer chromatography and reversed-phase high performance liquid chromatography].
    Li SQ
    Se Pu; 2001 Nov; 19(6):555-7. PubMed ID: 12545474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous cardiac glycosides, a new class of steroid hormones.
    Schoner W
    Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ascorbic acid: an endogenous inhibitor of isolated Na+,K+-ATPase.
    Ng YC; Akera T; Han CS; Braselton WE; Kennedy RH; Temma K; Brody TM; Sato PH
    Biochem Pharmacol; 1985 Jul; 34(14):2525-30. PubMed ID: 2990490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous cardiotonic steroids.
    Schoner W
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring.
    Manunta P; Hamilton BP; Hamlyn JM
    Hypertension; 2001 Feb; 37(2 Pt 2):472-7. PubMed ID: 11230321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and properties of endogenous ouabain-like substances from hemofiltrate and adrenal glands.
    Schoner W; Heidrich-Lorsbach E; Kirch U; Ahlemeyer B; Sich B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S29-31. PubMed ID: 7508021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain.
    Hamlyn JM; Lu ZR; Manunta P; Ludens JH; Kimura K; Shah JR; Laredo J; Hamilton JP; Hamilton MJ; Hamilton BP
    Clin Exp Hypertens; 1998; 20(5-6):523-33. PubMed ID: 9682908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia triggers release of an endogenous inhibitor of Na(+)-K(+)-ATPase from midbrain and adrenal.
    De Angelis C; Haupert GT
    Am J Physiol; 1998 Jan; 274(1):F182-8. PubMed ID: 9458838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy?
    Nicholls MG; Lewis LK; Yandle TG; Lord G; McKinnon W; Hilton PJ
    J Hypertens; 2009 Jan; 27(1):3-8. PubMed ID: 19050442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectral characterization of an endogenous digitalislike factor from human plasma.
    Mathews WR; DuCharme DW; Hamlyn JM; Harris DW; Mandel F; Clark MA; Ludens JH
    Hypertension; 1991 Jun; 17(6 Pt 2):930-5. PubMed ID: 1646172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin.
    Weiler EW; Gonick HC; Prins BA; Purdy RE; Weber MA
    Am J Med Sci; 1994 Jan; 307(1):27-35. PubMed ID: 8291503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal.
    Murrell JR; Randall JD; Rosoff J; Zhao JL; Jensen RV; Gullans SR; Haupert GT
    Circulation; 2005 Aug; 112(9):1301-8. PubMed ID: 16116051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the circulating ouabain-like compound ouabain?
    Gomez-Sanchez EP; Foecking MF; Sellers D; Blankenship MS; Gomez-Sanchez CE
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):647-50. PubMed ID: 7946167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.
    Tymiak AA; Norman JA; Bolgar M; DiDonato GC; Lee H; Parker WL; Lo LC; Berova N; Nakanishi K; Haber E
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8189-93. PubMed ID: 8396262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.